Study of BGG492 in Patients With Chronic Subjective Tinnitus
NCT01302873 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 96
Last updated 2017-03-22
Summary
This study will assess the efficacy of a two week treatment with BGG492 in patients with chronic subjective Tinnitus.
Conditions
- Chronic Subjective Tinnitus
Interventions
- DRUG
-
BGG492A
- DRUG
-
BGG492A
Sponsors & Collaborators
- lead INDUSTRY
Principal Investigators
-
Novartis Pharmaceuticals · Novartis Pharmaceuticals
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- QUADRUPLE
- Model
- CROSSOVER
Eligibility
- Min Age
- 18 Years
- Max Age
- 75 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2011-01-31
- Primary Completion
- 2012-01-31
- Completion
- 2012-01-31
Countries
- Germany
- Netherlands
Study Locations
More Related Trials
-
OTO-313 in Subjects With Subjective Tinnitus
NCT03918109 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Efficacy, Safety and Tolerability of Neramexane in Patients With Subjective Tinnitus
NCT00739635 ·Status: COMPLETED ·Phase: PHASE3
-
An Open-Label Study Evaluating Brexanolone in Adults With Tinnitus
NCT05645432 ·Status: COMPLETED ·Phase: PHASE2
-
OTO-313 in Subjects With Unilateral Subjective Tinnitus
NCT04829214 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy, Safety, Tolerability of Neramexane in Patients With Subjective Tinnitus
NCT00955799 ·Status: COMPLETED ·Phase: PHASE3
-
A Study Of The Effects Of PF-04958242 In Subjects With Age-Related Hearing Loss
NCT01518920 ·Status: COMPLETED ·Phase: PHASE1
-
Evaluating Possible Improvement in Tinnitus Severity After 28 Days Dosing of the Study Drug AUT00063 Compared to Placebo
NCT02315508 ·Status: COMPLETED ·Phase: PHASE2
-
AM-101 in the Treatment of Acute Tinnitus 3
NCT02040194 ·Status: COMPLETED ·Phase: PHASE3
-
Tinnitus Measured by MEG and Synchronous Neural Interaction™ Test: Template Development
NCT01185990 ·Status: UNKNOWN
-
Caroverin and Inner Ear Diseases
NCT01174979 ·Status: SUSPENDED ·Phase: PHASE3
-
TNF-α Treatment of Blast-Induced Tinnitus
NCT04066348 ·Status: RECRUITING ·Phase: PHASE2
-
Transcutaneous Auricular Vagus Nerve Stimulation for Meniere Disease
NCT05328895 ·Status: COMPLETED ·Phase: NA
-
AM-101 in the Treatment of Post-Acute Tinnitus 2
NCT02040207 ·Status: COMPLETED ·Phase: PHASE3
-
Noise-Induced Hearing Loss-Acute Exposure Treatment (UA)
NCT04774250 ·Status: TERMINATED ·Phase: PHASE2
-
Short-term Oral Prednisone for Acute Subjective Tinnitus
NCT05591144 ·Status: COMPLETED ·Phase: NA
-
Treatment Evaluation of Neuromodulation for Tinnitus - Stage A2
NCT03530306 ·Status: COMPLETED ·Phase: NA
-
Action of Intra-auricular Topical Lidocaine on Tinnitus
NCT05711641 ·Status: COMPLETED ·Phase: NA
-
Safety Study for NST-001 and the Neuroject Injection Set to Treat Tinnitus
NCT00957788 ·Status: TERMINATED ·Phase: PHASE1
-
Neramexane for Tinnitus
NCT00405886 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy of AM 101 in Patients With Acute Inner Ear Tinnitus
NCT00860808 ·Status: COMPLETED ·Phase: PHASE2
-
Clinical Trial of Acamprosate for Tinnitus
NCT00596531 ·Status: COMPLETED ·Phase: PHASE1
-
Sulodexide Efficacy in Chronic Idiopathic Subjective Tinnitus
NCT02737670 ·Status: COMPLETED ·Phase: PHASE2
-
Study to Evaluate SPI-1005 in Adults With Meniere's Disease
NCT02603081 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Different Dosing Regimens of STOP-AST
NCT06124703 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Nitrous Oxide Treatment for Tinnitus
NCT03365011 ·Status: COMPLETED ·Phase: PHASE4